Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155 GBX | 0.00% | +3.33% | -49.18% |
05-03 | Kelso raises stake in NCC; Transense joins project | AN |
04-30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.18% | 139M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals Reports 100% Response Rate in Phase 1 Trial of Myeloid Leukemia Combo Drug